Lichen Sclerosus
ICD-10 L90.0 · ICD-11 EB60

Genital Lichen Sclerosus in Adult Men: What to Do When Topical Calcineurin Inhibitors Have Not Controlled Symptoms

This protocol applies to men aged 18 and older with genital lichen sclerosus in whom topical calcineurin inhibitor therapy failed to achieve adequate symptom control. It defines the structured next step in management.

Clinical Scenario
Adult male patient (age ≥18) with confirmed genital lichen sclerosus.
Previous Treatment & Failure Condition
The prior treatment step employed topical calcineurin inhibitors — tacrolimus ointment or pimecrolimus cream — with the goal of suppressing symptoms including pruritus, burning, and dyspareunia. This protocol applies when those symptom-control targets were not achieved and escalation is warranted.
Next-Step Approach (partial overview)
When topical therapy is insufficient, the next management step involves surgical intervention — with the specific procedure selected according to the anatomical complication that is present. Procedural selection criteria, full surgical algorithm, and outcome benchmarks are in the complete protocol…
Treatment Goal
Healing of lichen sclerosus, including resolution of glans lesions and absence of LS signs and symptoms.
References
DOI: 10.1111/jdv.20083
View source ↗